RICHARD BINKS: Open Payments
NPI 1962085506 · QUEEN CREEK, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 64 payments from 16 companies in 2025. Trend: 2023 $457 · 2024 $809 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $342 |
| AstraZeneca Pharmaceuticals LP | 10 | $331 |
| Lilly USA, LLC | 6 | $101 |
| Exact Sciences Corporation | 4 | $83 |
| HydroCision, Inc. | 1 | $77 |
| Amgen Inc. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Novo Nordisk Inc | 3 | $44 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $36 |
Products named: AIRSUPRA, VRAYLAR, UBRELVY, JARDIANCE, QULIPTA, TENJET, FARXIGA, The Cologuard Plus Collection Kit.
Industry payments across AZ — which companies pay providers there.
